| An Evaluation of the Tolerability and Feasibility of combining 5-Amino-Levulinic Acid (5-ALA) with Carmustine Wafers (Gliadel) in the Surgical Management of Primary Glioblastoma (GALA-5 Trial) - Feasibility of 5-ALA and Carmustine wafers for Glioblastoma (GALA-5) | An Evaluation of the Tolerability and Feasibility of combining 5-Amino-Levulinic Acid (5-ALA) with Carmustine Wafers (Gliadel) in the Surgical Management of Primary Glioblastoma (GALA-5 Trial) - Feasibility of 5-ALA and Carmustine wafers for Glioblastoma (GALA-5) | EUCTR2010-022496-66-GB |
